Headline News

 

Pfizer Announces FDA Approval for Oncology Biosimilar Trazimera

Posted on March 18, 2019

Pall Corporation and ARTeSYN Biosolutions Collaboration Agreement Expanded to Accelerate Single-Use Technology Industrialization

Posted on March 14, 2019

Suven Life Sciences Announces the Asset Purchase Agreement of Rising Pharmaceuticals Through its Joint Venture Partner, Shore Suven Pharma Inc.

Posted on March 12, 2019

Roche’s VENTANA PD-L1 (SP142) Assay Approved as First Companion Diagnostic to Identify Triple-Negative Breast Cancer Patients Eligible for Treatment with Tecentriq in Combination with Abraxane

Posted on March 12, 2019

Two USFDA Approvals Recieved by Laurus Labs

Posted on March 12, 2019

EMA Validates Application for BAVENCIO® (AVELUMAB) Plus INLYTA® (AXITINIB) for the Treatment of Advanced Renal Cell Carcinoma

Posted on March 12, 2019

Regeneron announce FDA Approval for DUPIXENT® (DUPILUMAB) Moderate-To-Severe Atopic Dermatitis in Adolescents

Posted on March 12, 2019

Regeneron and GSK Make New Genetic Data on 50,000 UK BioBank Participants Available to Global Health Research Community

Posted on March 12, 2019

GE Healthcare and Amgen Digitally Collaborate to Improve Biomanufacturing Performance Reliability

Posted on March 12, 2019

Pall Corporation and Broadley-James Cooperate to Deliver Next Generation Single-Use Sensor Technologies to the Life Science Market

Posted on March 12, 2019

Sartorius Stedim Biotech and Novasep to develop novel systems for membrane chromatography

Posted on March 05, 2019

Sanofi Announce CHMP Recommends Approval of Dupixent® (dupilumab) for Asthma Indication

Posted on March 05, 2019

Emergex Weclomes Dr. Athanasios Papadopoulos joins as Chief Medical Officer

Posted on March 05, 2019

Presentation of New Subtype Analysis of GBR 830, an Investigational, Anti-OX40 Monoclonal Antibody Announced by Glenmark Pharmaceuticals at the American Academy of Dermatology Annual Meeting

Posted on March 05, 2019

Positive CHMP Opinion Received by Pfizer for LORVIQUA® (LORLATINIB) for Certain Adult Patients with Previously-Treated Alk-Positive Advanced Non-Small Cell Lung Cancer

Posted on March 05, 2019